Gaudium IVF and Women Health Ltd (GAUDIUMIVF) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Gaudium IVF and Women Health Ltd on NSE and BSE, with an AI summary of each filing.
Voting Results and Consolidated Scrutinizer''s Report of 11th Annual General Meeting of the Company.
Annual General Meeting · 30 Sept 2026, 3:52 am
Proceeding of 11th Annual General Meeting of the Company held on Monday, September 28, 2026.
Annual General Meeting · 29 Sept 2026, 3:12 am
Intimation regarding commencement of commercial operations at Company''s new IVF Centre/Hub at Gurgaon, Haryana
Others (Uncategorized) · 25 Sept 2026, 2:50 am
Gaudium IVF Commences Commercial Operations at New Gurgaon Centre In line with the IPO objects outlined in its prospectus dated 25th Feb'26, Gaudium IVF and Women Health Limited commenced commercial operations at its new IVF Centre/Hub in Gurugram, Haryana, effective 24th Sep'26. Located at Civil Lines, Gurugram, the facility offers comprehensive fertility and healthcare services. The centre is equipped with advanced reproductive infrastructure, standardized clinical protocols, and the proprietary Gaudium Signature Lab featuring AI-powered embryology technologies.
Letter to Shareholders providing the weblink and navigation path for accessing the Annual Report for the Financial Year 2025-26 pursuant to Regulation 36(1)(b) of Listing Regulations.
Annual Report · 04 Sept 2026, 1:45 am
Annual Report of the Company for the Financial Year 2025-26.
Others (Uncategorized) · 03 Sept 2026, 7:26 pm
Notice of 11th Annual General Meeting to be held on Monday, September 28, 2026 at 02:00 P.M. (IST) through VC/OAVM
Annual General Meeting · 03 Sept 2026, 7:08 pm
Transcript of Earnings Call on Unaudited Standalone and Consolidated Financial Resullts for the quarter ended June 30, 2026.
Transcript · 19 Aug 2026, 11:39 pm
Gaudium IVF and Women Health Limited has informed the Exchange about Audio recording of the Earnings Call on the Financial Results for the quarter ended June 30, 2026.
Audio / Video · 14 Aug 2026, 11:54 pm
Gaudium IVF Publishes Earnings Call Recording for Q1 FY27 Gaudium IVF and Women Health Limited has uploaded the audio recording of its earnings call held on 14 Aug'26. The call discussed the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. This action complies with SEBI's disclosure requirements. The recording is now accessible on the company's website.
Revised Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026
Investor Presentation · 14 Aug 2026, 3:54 pm
Gaudium IVF Revises Q1 FY27 EBITDA on One-Time Cost Disclosure Gaudium IVF issued a revised Q1 FY27 investor presentation on 14 Aug'26, incorporating corrections from its 13 Aug'26 submission. The update includes a one-time marketing expense of Rs. 253.24 lakhs. This revision impacts profitability metrics for the quarter ended 30 Jun'26. Consequently, the standalone Adjusted EBITDA is now Rs. 507.75 lakhs with a 37.12% margin. The consolidated Adjusted EBITDA stands at Rs. 532.75 lakhs, representing a 27.49% margin. These adjustments follow expansion-related costs and investments in AI-led embryology tools.
Investor Presentation on the Financial Results of the Company for the quarter ended June 30, 2026.
Investor Presentation · 14 Aug 2026, 4:58 am
Gaudium IVF Q1FY27: Revenue Up, Margin Squeezed by Expansion Costs Gaudium IVF reported consolidated Q1FY27 results, with revenue from operations growing 9.13% YoY to Rs 19.38 Cr. However, EBITDA fell 52.96% YoY to Rs 2.42 Cr, and PAT declined 42.27% to Rs 1.78 Cr. The significant margin compression, with EBITDA margin at 12.51% (down 1651 bps) and PAT margin at 9.17% (down 816 bps), is attributed to front-loaded expansion costs for new hubs and integration of AI technology. Adjusted EBITDA was reported at Rs 5.33 Cr, with a 27.49% margin.
Monitoring Agency Report for the quarter ended June 30, 2026.
Others (Uncategorized) · 14 Aug 2026, 3:56 am
Gaudium IVF: IPO Proceeds Utilization Report for Q1 FY27 As of 30 Jun'26, Gaudium IVF has utilized ₹34.03 crore (37.8%) of its ₹90 crore IPO proceeds. Key utilisations include ₹18.07 crore for debt repayment, ₹7.72 crore for issue expenses, and ₹7.21 crore for general corporate purposes (GCP). Of the ₹50 crore earmarked for new IVF centres, only ₹1.03 crore has been spent. The Board noted a delay in capex, shifting the timeline from FY26 to FY27. Of the GCP, ₹5.76 crore funded the Lucknow Women's Hospital. Unutilized proceeds total ₹55.97 crore.
Press Release on the Unaudited Financial Results of the Compony for the quater ended June 30, 2026.
Press Release · 14 Aug 2026, 1:55 am
Gaudium IVF: Expansion Costs Pressure Q1 Margins Despite Revenue Growth Gaudium IVF reported Q1FY27 results ending 30 Jun'26, with revenue up 9.13% YoY to ₹19.4 Cr, driven by mature hubs. However, expansion-related investments ahead of new hub rollouts caused a sharp decline in profitability. EBITDA fell 52.96% YoY to ₹2.4 Cr, with EBITDA margin contracting 1651 bps to 12.51%. Consequently, PAT dropped 42.27% to ₹1.8 Cr. The company commenced operations at its new South Extension hub and approved a new hospital in Lucknow, signaling continued focus on network expansion.
Intimation of Statement of Deviation & Variation of Funds for the quater ended June 30, 2026
Others (Uncategorized) · 14 Aug 2026, 1:43 am
Gaudium IVF Q1 FY27 Results and Board Meeting Update Gaudium IVF reported Q1 FY27 consolidated net profit of ₹177.59 lakh, down 42.27% YoY, on revenue of ₹1,937.66 lakh (+9.13% YoY). The Board approved results, re-appointed Ram Rattan & Associates as Internal Auditor for FY27, and appointed Suresh Nainwal & Company as Secretarial Auditor for five years. The 11th AGM is scheduled for 28 Sep'26. Following full repayment of loans, the Board reallocated ₹192.63 lakh of unutilized IPO funds from debt repayment to General Corporate Purposes, keeping it within the 25% gross proceeds limit.
Appointment of Secretarial Auditor of the Company for a term of 5 Years, subject to approval of the shareholders of the Company at the ensuing Annual General Meeting of the Company.
Change in Management · 14 Aug 2026, 1:15 am
Appointment of Internal Auditor of the Company for the Financial Year 2026-27.
Change in Management · 14 Aug 2026, 1:05 am
Gaudium IVF Q1 FY27 Results and Board Meeting Update Gaudium IVF reported Q1 FY27 consolidated net profit of ₹177.59 lakh, a 42.27% YoY decline, on revenue of ₹1,937.66 lakh, up 9.13% YoY. The board, in its 13-Aug'26 meeting, approved these unaudited results. Key decisions included reappointing Ram Rattan & Associates as Internal Auditor for FY27 and appointing Suresh Nainwal & Company as Secretarial Auditor for a five-year term from FY27 to FY31. The 11th AGM is scheduled for 28-Sep'26. The board also reallocated ₹192.63 lakh of unutilised IPO funds from debt repayment to general corporate purposes.
Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026
Financial Result · 14 Aug 2026, 12:43 am
Gaudium IVF and Women Health Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakhs) ■ Revenue: 1,938 (+9.1% YoY | -36.2% QoQ) ■ EBITDA: 242 (-53.0% YoY | -80.1% QoQ) ■ EBITDA Margin (%): 12.5 (-1651 bps YoY | -2759 bps QoQ) ■ PAT: 178 (-42.3% YoY | -78.8% QoQ) ■ EPS (INR): 0.25 (-50.0% YoY | -81.3% QoQ)
Unaudited Standalone and Consolidated Financial Results for the Quarter ended June 30, 2026
Outcome · 14 Aug 2026, 12:33 am
Gaudium IVF Q1 FY27 Results and Board Meeting Update Gaudium IVF reported Q1 FY27 consolidated net profit of ₹177.59 lakhs, down 42.2% YoY, on revenue of ₹1,937.66 lakhs, up 9.1% YoY. EBITDA declined 42.4% YoY to ₹287.38 lakhs. The Board approved Q1 financial results on 13th Aug'26, re-appointed Ram Rattan & Associates as Internal Auditor for FY27, and approved the appointment of Suresh Nainwal & Company as Secretarial Auditor for a five-year term. The 11th AGM is scheduled for 28th Sep'26. Unutilized IPO funds from loan repayment (₹192.63 lakhs) will be reallocated to General Corporate Purposes.
Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you ....
Intimation · 14 Aug 2026, 2:00 pm
Gaudium IVF Schedules Q1 FY27 Earnings Conference Call Gaudium IVF and Women Health Limited has scheduled its Q1 FY27 earnings conference call for Fri, 14 Aug'26, at 02:00 PM IST. The management will discuss the unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. Key participants will include Chairperson & MD Dr. Manika Khanna, Non-Executive Director Mr. Vishad Khanna, and CFO Mr. Rakesh K. Sharma. Dial-in details are available for both domestic and international participants.
Gaudium IVF And Women Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the Un-audited ....
Intimation · 13 Aug 2026, 5:30 am
Gaudium IVF Board Meeting Set to Approve Q1FY27 Financial Results Gaudium IVF and Women Health Limited has scheduled a Board of Directors meeting for 13 Aug'26 to consider and approve its unaudited standalone and consolidated financial results for the quarter ended 30 Jun'26. The company also confirmed that its trading window for designated persons has been closed since 01 Jul'26 and will reopen 48 hours after the results are declared. This is a standard procedure ahead of quarterly earnings announcements.
Press Release- India''s First Listed IVF Company, Gaudium IVF, Unveils AI Powered Signature Labs, Kicking Off Planned 19 Centre Expansion
Press Release · 16 Jul 2026, 7:02 pm
Gaudium IVF Launches AI-Powered Labs, Initiating 19-Centre Expansion Gaudium IVF and Women Health Limited (GAUDIUMIVF), India's first listed IVF chain, launched its first new centre in South Delhi on 16 Jul'26, initiating its planned 19-centre expansion outlined during its IPO. The new facility features the proprietary "Signature Lab" model, integrating AI-powered embryology technologies like SID and ERICA for advanced sperm and embryo assessment. This standardised, high-tech laboratory framework will be replicated across all new centres to ensure consistent clinical excellence, aiming to reinforce the company's leadership in India's growing fertility care market.
Intimation regarding commencement of commercial operations at Company''s new IVF Centre/Hub at South Extension, New Delhi
Others (Uncategorized) · 16 Jul 2026, 1:58 am
Gaudium IVF Commences Operations at New Centre in South Extension, New Delhi Gaudium IVF and Women Health Limited announced the commencement of commercial operations at its new IVF Centre/Hub in South Extension, New Delhi, effective 16 Jul'26. This expansion, funded by its IPO proceeds as per the prospectus dated 25 Feb'26, aims to provide In Vitro Fertilization (IVF) and related healthcare services. The new facility is equipped with advanced embryology labs and modern medical infrastructure, signaling the company's ongoing network expansion and utilization of capital for growth.
Gaudium IVF and Women Health Limited has informed the Exchange about Corrigendum to the Financial Results submitted for the quarter and year ended March 31, 2026
Others (Uncategorized) · 26 Jun 2026, 3:10 am
Gaudium IVF Issues Corrigendum for FY25 Consolidated Financials Gaudium IVF filed a corrigendum on 25 Jun'26 to rectify inadvertent errors in its consolidated results for the year ended 31 Mar'25, originally submitted on 28 May'26. The corrections relate to regrouping of comparative figures and do not impact FY26 results, net worth, or cash flows. Corrected FY25 consolidated PAT is now ₹1,913.13 lakhs versus the previously reported ₹1,913.00 lakhs. Standalone financials, total current assets, and total current liabilities for FY25 remain unchanged. Auditors confirmed no modification to their report is needed.
Approval for setting up of Gaudium Women Hospital at Lucknow, Uttar Pradesh
Others (Uncategorized) · 25 Jun 2026, 8:06 pm
Gaudium IVF Approves New Women's Hospital in Lucknow with ₹15 Crore CAPEX Gaudium IVF's Board approved the establishment of a new Gaudium Women Hospital in Lucknow on 25 Jun'26. The project, with an estimated CAPEX of up to ₹15 crore, will be executed via a long-term lease arrangement with a non-promoter party. The 30-year lease includes a 15-year lock-in and a revenue-sharing model where Gaudium pays the landowner 10% of net revenue. The company will place a refundable security deposit of ₹3 crore, which will be adjusted against the initial revenue share payments.
Gaudium IVF and Women Health Limited has informed the Exchange about Schedule of meet
Intimation · 09 Jun 2026, 1:23 am
Gaudium IVF Announces Analyst Meeting at InsightX Conference Gaudium IVF and Women Health Limited will participate in the InsightX Conference, organized by Choice Broking. The virtual meeting is scheduled for 12th Jun'26, from 11:00 AM to 12:00 PM. Discussions will be based solely on publicly available information, with no formal presentation or sharing of unpublished price-sensitive information. The schedule is subject to potential changes.
Audio recording of Q4 & FY26 Earnings Conference Call
Audio / Video · 29 May 2026, 9:33 pm
Gaudium IVF Makes Q4 & FY26 Earnings Call Recording Available Gaudium IVF and Women Health Limited announced on 29 May'26 that the audio recording of its earnings call is now accessible on the company's website. The call discussed the audited standalone and consolidated financial results for the quarter and fiscal year ending 31 Mar'26. This follows SEBI (LODR) Regulations, 2015, providing investors and stakeholders with direct access to management's discussion and analysis of the financial performance.